Home › Core › ISCC-IDs › 28C3c48gU9vn3

View ISCC-ID

Core Data

28C3c48gU9vn3
ISCC-ID - digital asset identifier
CCXVxsXDFX1az-CTEribitcagTc-CDBoAjzMAQqwP-CRa8tZp5tNA3A
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

is folfirinox suitable for chinese patients with locally advanced pancreatic cancer

Ledger Reference

coblo
Source Ledger/Blockchain
12402233
N-th ISCC Decleration on source ledger
4fb3bd99123bc0f5ada76a97eaffdc84528d9d265f5d856616e68955f41a0a55
Hash of block that includes the ISCC-DECLARATION
4a09ac07518b3ad961b98c07597b6d9eb4ee43ce7af629c1385748594f5d0709
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Is FOLFIRINOX suitable for Chinese patients with locally advanced pancreatic cancer?", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "T. Liang", "@type": "Person"}, {"name": "X. Bai", "@type": "Person"}, {"name": "X. Li", "@type": "Person"}, {"name": "C. Guo", "@type": "Person"}, {"name": "Q. Li", "@type": "Person"}, {"name": "S. Wei", "@type": "Person"}], "license": "elsevier-specific: oa user license", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://www.hpbonline.org/article/S1365182X18333495/pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Elsevier BV", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1016/j.hpb.2018.06.1969", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCXVxsXDFX1az-CTEribitcagTc-CDBoAjzMAQqwP-CRa8tZp5tNA3A", "propertyID": "ISCC"}], "datePublished": "2018-09-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close